Future Oncology · 2019 · 38 citations · 32 references
MedicineBiostatisticsOncologyCancer ImmunologyOncologic SurgeryTumor ImmunologyBiomarker-guided Therapy SelectionCancer BiomarkersColorectal CancerImmuno-oncology BiomarkersResponse AssessmentTherapy Response AssessmentBlood-based BiomarkersLogistic RegressionLogistic Regression AnalysisNeoadjuvant ChemoradiotherapyNeutrophil-to-lymphocyte RatioPlatelet-to-lymphocyte RatioPredictive Biomarkers Of ResponsePredictive Tumor Markers
Aim: To evaluate the value of pretreatment blood biomarkers in predicting pathologic responses to neoadjuvant chemoradiotherapy (neo-CRT) in patients with locally advanced rectal cancer. Materials & methods: We conducted logistic regression analysis and receiver operating characteristic to assess the predictive value of blood biomarkers. The outcome was defined by the pathologic complete response and good response. Results: Carcinoembryonic antigen (CEA) (p < 0.001), neutrophil-to-lymphocyte ratio (p = 0.024), platelet-to-lymphocyte ratio (p = 0.006) and lymphocyte-to-monocyte ratio (LMR) (p < 0.001) were significant predictors of pathologic complete response, with area under the curve of 0.785, 0.794, 0.740 and 0.913, respectively; CEA (p = 0.007) and LMR (p < 0.001) correlated significantly with good response, with area under the curve of 0.743 and 0.771, respectively. Conclusion: Lower LMR and higher CEA, neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio before treatment could predict poorer pathologic response to neo-CRT in patients with locally advanced rectal cancer.
32
Chemotherapy with Preoperative Radiotherapy in Rectal Cancer
Jean-François Bosset, Laurence Collette, G. Calais et al. · New England Journal of Medicine · 2006 · 2.7K citations · Full text
Rolf Sauer, Torsten Liersch, Susanne Merkel et al. · Journal of Clinical Oncology · 2012 · 2.1K citations · Full text